Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group

Cancer Science

Volumn 99, Issue 11, 2008, Pages 2238-2243

  Tsuchida, Ken ^a   Komatsu, Kenshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; MITOMYCIN C;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DOT HYBRIDIZATION; DRUG SENSITIVITY; FANCONI ANEMIA; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MOUSE; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; WILD TYPE;

ANIMALS; BRCA2 PROTEIN; CELL LINE; CRICETINAE; DNA; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HUMANS; MICE; NIJMEGEN BREAKAGE SYNDROME;

EID: 55449092960     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00915.x     Document Type: Article

References (47)

1. McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand crosslinks: Molecular mechanisms and clinical relevance. Lancet Oncol 2001; 2: 483-90.
2. Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutat Res 2001; 486: 217-47.
3. Legerski RJ, Richie C. Mechanisms of repair of interstrand crosslinks in DNA. Cancer Treat Res 2002; 112: 109-28.
4. Petersen LN, Mamenta EL, Stevnsner T, Chaney SG, Bohr VA. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity. Carcinogenesis 1996; 17: 2597-602.
5. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003; 3: 23-34.
6. Smogorzewska A, Matsuoka S, Vinciguerra P et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007; 129: 289-301.
7. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory C, Grompe M, D'Andrea D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 2002; 100: 2414-20.
8. Kalb R, Neveling K, Hoehn H et al. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet 2007; 80: 895-910.
9. Garcia-Higuera I, Taniguchi T, Ganesan S et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7: 249-62.
10. Reid S, Schindler D, Hanenberg H et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 2007; 39: 162-4.
11. Xia B, Sheng Q, Nakanishi K et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 2006; 22: 719-29.
12. Xia B, Dorsman JC, Ameziane N et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 2007; 39: 159-61.
13. Levitus M, Waisfisz Q, Godthelp BC et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet 2005; 37: 934-5.
14. Godthelp BC, Wiegant WW, Waisfisz Q et al. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat Res 2006; 594: 39-48.
15. Litman R, Peng M, Jin Z et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 2005; 8: 255-65.
16. Vandenberg CJ, Gergely F, Ong CY et al. BRCA1-independent ubiquitination of FANCD2. Mol Cell 2003; 12: 247-54.
17. Meetei AR, Yan Z, Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 2004; 3: 179-81.
18. Hanada K, Budzowska M, Modesti M et al. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J 2006; 25: 4921-32.
19. Kuraoka I, Kobertz WR, Ariza RR, Biggerstaff M, Essigmann JM, Wood RD. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/ recombination nuclease. J Biol Chem 2000; 275: 26632-6.
20. Niedernhofer LJ, Odijk H, Budzowska M et al. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol 2004; 24: 5776-87.
21. Kennedy RD, D'Andrea AD. The Fanconi Anemia/BRCA pathway: New faces in the crowd. Genes Dev 2005; 19: 2925-40.
22. Wang X, Peterson CA, Zheng H, Nairn RS, Legerski J, Li L. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol 2001; 21: 713-20.
23. Zheng H, Wang X, Legerski RJ, Glazer PM, Li L. Repair of DNA interstrand cross-links: Interactions between homology-dependent and homology-independent pathways. DNA Repair 2006; 5: 566-74.
24. Niedzwiedz W, Mosedale G, Johnson M, Ong CY, Pace P, Patel KJ. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell 2004; 15: 607-20.
25. Yamamoto K, Ishiai M, Matsushita N et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol 2003; 23: 5421-30.
26. Nakanishi K, Yang YG, Pierce AJ et al. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci 2005; 102: 1110-5.
27. Kobayashi J, Antoccia A, Tauchi H, Matsuura S, Komatsu K. Nbs1 and its functional role in the DNA damage response. DNA Repair 2004; 3: 855-61.
28. Tauchi H, Kobayashi J, Morishima K et al. Nbs is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 2002; 420: 93-8.
29. Nakanishi K, Taniguchi T, Ranganathan V et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002; 4: 913-20.
30. De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol 2000; 20: 7980-90.
31. Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: Evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol 2004; 24: 123-34.
32. Brendel M, Ruhland A. Relationships between functionality and genetic toxicology of selected DNA-damaging agents. Mutat Res 1984; 133: 51-85.
33. Zhang Y, Price BD, Tetradis S, Chakrabarti S, Maulik G, Makrigiorgos GM. Reproducible and inexpensive probe preparation for oligonucleotide arrays. Nucleic Acids Res 2001; 29: E66.
34. Shi YB, Spielmann HP, Hearst E. Base-catalyzed reversal of a psoralen-DNA cross-link. Biochemistry 1988; 27: 5174-8.
35. Yeung AT, Dinehart WJ, Jones BK. Alkali reversal of psoralen cross-link for the targeted delivery of psoralen monoadduct lesion. Biochemistry 1988; 27: 6332-8.
36. Kanne D, Straub K, Rapoport H, Hearst JE. Psoralen-deoxyribonucleic acid photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5′ 8-trimethylpsoralen. Biochemistry 1982; 21: 861-71.
37. Larminat F, Bohr VA. Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage. Nucl Acids Res 1994; 22: 3005-10.
38. Bessho T, Sancar A, Thompson H, Thelen MP. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem 1997; 272: 3833-7. 3833-3837
39. Zhang N, Zhang X, Peterson C, Li L, Legerski R. Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts. Nucl Acids Res 2000; 28: 4800-4.
40. Andersson BS, Sadeghi T, Siciliano MJ, Legerski R, Murray D. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol 1996; 38: 406-16.
41. Hoy CA, Thompson LH, Mooney CL, Salazar EP. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res 1985; 45: 1737-43.
42. Bishop DK, Ear U, Bhattacharyya A, Calderone C, Beckett M, Weichselbaum RR, Shinohara A. Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem 1998; 273: 21482-8.
43. Liu N, Lamerdin JE, Tebbs RS et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell 1998; 1: 783-93.
44. Caldecott K, Jeggo P. Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutat Res 1991; 255: 111-21.
45. Zheng H, Wang X, Warren AJ et al. Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol 2003; 23: 754-61.
46. Hinz JM, Nham PB, Urbin SS, Jones IM, Thompson LH. Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucl Acids Res 2007; 35: 3733-40.
47. Zhang N, Liu X, Li L, Legerski R. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA Repair 2007; 6: 1670-8.